{
  "docId": "019de073-1466-7584-8ab0-d467e4eba908",
  "docSlug": "8094e1caeccf03c1e07a7f57c9f4c117",
  "documentTitle": "AbCellera | Investor Presentation Deck | 37 slides",
  "authorId": "abcellera",
  "authorName": "AbCellera",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 3,
  "pageCount": 37,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "problem_statement",
  "function": "frame_problem",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "Uses a bar chart to visualize the acceleration of FDA approvals over time.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-1466-7584-8ab0-d467e4eba908/3",
  "deckHref": "/decks/019de073-1466-7584-8ab0-d467e4eba908",
  "deckJsonHref": "/decks/019de073-1466-7584-8ab0-d467e4eba908.json",
  "deckAnchorHref": "/decks/019de073-1466-7584-8ab0-d467e4eba908#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.2,
        "w": 0.3,
        "x": 0.65,
        "y": 0.28
      },
      "kind": "callout",
      "text": "BRING BETTER ANTIBODIES TO PATIENTS, FASTER.",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "057dcfa1-6d44-4a00-8dc8-d499c25707ab",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.4,
        "x": 0.095,
        "y": 0.55
      },
      "kind": "chart",
      "text": "Bar chart showing FDA approvals of antibodies from 1986 to 2021",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "83ad3f22-e775-438b-a4de-3c09c9c860c9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.1,
        "x": 0.51,
        "y": 0.45
      },
      "kind": "metric",
      "text": "6 years",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "21eb0749-d34d-426b-9c82-3cbaa2d9fbf3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.1,
        "x": 0.11,
        "y": 0.65
      },
      "kind": "metric",
      "text": "29 years",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f01795ce-bfc2-4d90-b61e-be68f492c0d5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.3,
        "x": 0.65,
        "y": 0.6
      },
      "kind": "paragraph",
      "text": "We deliver lead candidates in less time and with a higher probability of success.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "79f63f3f-55b6-455b-b6e6-cee4594d22fd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.35,
        "x": 0.095,
        "y": 0.22
      },
      "kind": "paragraph",
      "text": "LIMITED TECHNOLOGIES & FRAGMENTED APPROACHES can't keep pace with antibody drug discovery.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d6d5e956-e68e-49bd-9ea4-0df71da54e4a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.5,
        "x": 0.1,
        "y": 0.93
      },
      "kind": "source-note",
      "text": "* As at May 2021. Source: Nature Reviews: FDA approves 100th monoclonal antibody product",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b3fb6aa7-c399-45e4-bd26-480aa772c54d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.15,
        "x": 0.095,
        "y": 0.15
      },
      "kind": "title",
      "text": "THE PROBLEM",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1321e725-fd97-486d-8afb-a61e01219fc3",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Problem Statement Canvas",
      "slug": "problem-statement-canvas",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "91a53916-1b99-45bc-9724-357b7720e089",
      "evidence": "The slide presents a problem statement with a clear description of the issue and its consequences.",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "before-after-framing",
      "slug": null,
      "matchId": "8ce11350-0bea-45b3-8adf-2b2585c04da9",
      "evidence": "Contrasts the slow historical 'problem' with the 'solution' of speed.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 3,
      "from": 3,
      "beatId": "555ab906-cdcd-467c-8ad5-b323d06a9949",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Problem",
      "beatSlug": "sequoia-pitch-problem",
      "evidence": "The problem statement is presented on page 3.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 9,
      "from": 3,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "1ed621e7-b71c-4080-879a-cc9beb68a264",
      "evidence": "The problem statement and traction sections imply the costs of inaction.",
      "position": 0,
      "objective": "What are the consequences of not adopting AbCellera's platform?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}